Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

SAP: Negative read across from Workday's Q1 FY16 results

NEUTRAL, Fair Value EUR68 (+1%)

Published last May Wednesday 27, 2015

Alten: Feedback from Paris investor roadshow

NEUTRAL, Fair Value EUR42 (-4%)

Published last May Wednesday 27, 2015

Richemont: Price adjustments in dollar zone explain the sales decline in April

BUY, Fair Value CHF100 (+16%)

Published last May Tuesday 26, 2015

Consumer Groups Q1 takeaways: globally reassuring!

Published last May Tuesday 26, 2015

AstraZeneca: Amgen leaves AstraZeneca alone with brodalumab

NEUTRAL, Fair Value 4830p vs. 4860p (+8%)

Published last May Tuesday 26, 2015

Pernod Ricard: Martell enjoys growth opportunities

BUY-Top Picks, Fair Value EUR129 (+15%)

Published last May Tuesday 26, 2015

Food retailing: FMCG in Europe

Published last May Thursday 21, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities